SHL joins Partnership Opportunities in Drug Delivery
SHL will proudly make its first appearance at the 2019 Partnership Opportunities in Drug Delivery (PODD) conference from October 7-8 in Boston.
The company’s debut exhibit will feature a vast array of products that provide solutions for the growing demands in self-injection treatments. Displays include Needle Isolation Technology (NIT®) – a pre-attached needle mechanism for cartridge-based autoinjectors that eliminates the need for users to manually attach the needle or directly contact with the needle upon injection preparation; the refined Molly® variation – an autoinjector family that offers devices for drug fill volumes up to 2.25mL and is designed to be mass-produced effectively and efficiently.
Owning 30 years of experience and industry knowledge, SHL continues to thrive in the self-injection treatment space, offering pharma companies a broad scope of services that include the design, development, and manufacturing of advanced drug delivery systems.
Visit SHL at Booth 24 at the Renaissance Boston Waterfront Hotel.
